skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 13,504  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Female remove subject: Life Sciences & Biomedicine remove subject: Patients remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Precision Medicine: From Science To Value
Material Type:
Article
Add to My Research

Precision Medicine: From Science To Value

Health Affairs, 2018-05, Vol.37 (5), p.694-701 [Peer Reviewed Journal]

Copyright The People to People Health Foundation, Inc., Project HOPE May 2018 ;ISSN: 0278-2715 ;EISSN: 1544-5208 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.2017.1624 ;PMID: 29733705

Full text available

2
Opportunities and priorities for breast surgical research
Material Type:
Article
Add to My Research

Opportunities and priorities for breast surgical research

The lancet oncology, 2018-10, Vol.19 (10), p.e521-e533 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 2018 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(18)30511-4 ;PMID: 30303126

Full text available

3
“About sixty per cent I want to do it”: Health researchers’ attitudes to, and experiences of, patient and public involvement (PPI)—A qualitative interview study
Material Type:
Article
Add to My Research

“About sixty per cent I want to do it”: Health researchers’ attitudes to, and experiences of, patient and public involvement (PPI)—A qualitative interview study

Health expectations : an international journal of public participation in health care and health policy, 2019-08, Vol.22 (4), p.721-730 [Peer Reviewed Journal]

2019 The Authors published by John Wiley & Sons Ltd ;2019 The Authors Health Expectations published by John Wiley & Sons Ltd. ;COPYRIGHT 2019 John Wiley & Sons, Inc. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1369-6513 ;EISSN: 1369-7625 ;DOI: 10.1111/hex.12883 ;PMID: 30927334

Full text available

4
Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors
Material Type:
Article
Add to My Research

Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors

The Journal of clinical investigation, 2019-05, Vol.129 (5), p.2056-2070 [Peer Reviewed Journal]

COPYRIGHT 2019 American Society for Clinical Investigation ;COPYRIGHT 2019 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation May 2019 ;2019 American Society for Clinical Investigation 2019 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI99538 ;PMID: 30835255

Full text available

5
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
Material Type:
Article
Add to My Research

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

The Lancet (British edition), 2012-02, Vol.379 (9814), p.432-444 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 4-Feb 10, 2012 ;2012 Elsevier Ltd. All rights reserved. 2012 Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)61625-5 ;PMID: 22152853 ;CODEN: LANCAO

Full text available

6
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
Material Type:
Article
Add to My Research

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

The Lancet (British edition), 2012-06, Vol.379 (9834), p.2352-2363 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 23-Jun 29, 2012 ;2012 Elsevier Ltd. All rights reserved. 2012 Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60768-5 ;PMID: 22632908 ;CODEN: LANCAO

Full text available

7
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles
Material Type:
Article
Add to My Research

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

The Lancet (British edition), 2013-05, Vol.381 (9880), p.1817-1826 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 25, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)60313-X ;PMID: 23615461 ;CODEN: LANCAO

Full text available

8
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Material Type:
Article
Add to My Research

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

The Lancet (British edition), 2011-06, Vol.377 (9783), p.2103-2114 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 18-Jun 24, 2011 ;2011 Elsevier Ltd. All rights reserved. 2011 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60613-2 ;PMID: 21641636 ;CODEN: LANCAO

Full text available

9
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Material Type:
Article
Add to My Research

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

The Lancet (British edition), 2011-06, Vol.377 (9784), p.2181-2192 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 25-Jul 1, 2011 ;2011 Elsevier Ltd. All rights reserved. 2011 Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60739-3 ;PMID: 21663949 ;CODEN: LANCAO

Full text available

10
What advanced cancer patients with limited treatment options know about clinical research: a qualitative study
Material Type:
Article
Add to My Research

What advanced cancer patients with limited treatment options know about clinical research: a qualitative study

Supportive care in cancer, 2017-10, Vol.25 (10), p.3235-3242 [Peer Reviewed Journal]

Springer-Verlag Berlin Heidelberg 2017 ;COPYRIGHT 2017 Springer ;Supportive Care in Cancer is a copyright of Springer, 2017. ;ISSN: 0941-4355 ;EISSN: 1433-7339 ;DOI: 10.1007/s00520-017-3734-4 ;PMID: 28488050

Full text available

11
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Material Type:
Article
Add to My Research

Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet, 2020-10, Vol.396 (10259), p.1345-1352 [Peer Reviewed Journal]

2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by/4.0 ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32013-4 ;PMID: 33031764

Digital Resources/Online E-Resources

12
Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial
Material Type:
Article
Add to My Research

Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial

The Lancet (British edition), 2011-03, Vol.377 (9768), p.823-836 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;2011. Elsevier Ltd ;Copyright Elsevier Limited Mar 5-Mar 11, 2011 ;2011 Elsevier Ltd. All rights reserved. 2011 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60096-2 ;PMID: 21334061 ;CODEN: LANCAO

Full text available

13
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
Material Type:
Article
Add to My Research

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial

The lancet oncology, 2020-04, Vol.21 (4), p.508-518 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30074-7 ;PMID: 32135080

Full text available

14
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Material Type:
Article
Add to My Research

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet (British edition), 2021-05, Vol.397 (10285), p.1637-1645 [Peer Reviewed Journal]

2021 Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2021 Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00676-0 ;PMID: 33933206

Full text available

15
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
Material Type:
Article
Add to My Research

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

New England Journal of Medicine, 2021-10, Vol.385 (16), p.1474-1484 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2109072 ;PMID: 34320281

Digital Resources/Online E-Resources

16
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
Material Type:
Article
Add to My Research

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials

The lancet oncology, 2020-04, Vol.21 (4), p.531-540 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30856-3 ;PMID: 32105622

Full text available

17
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Material Type:
Article
Add to My Research

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet (British edition), 2021-02, Vol.397 (10274), p.605-612 [Peer Reviewed Journal]

2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00149-5 ;PMID: 33545096

Full text available

18
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial
Material Type:
Article
Add to My Research

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

The Lancet (British edition), 2011-07, Vol.378 (9786), p.156-167 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 9-Jul 15, 2011 ;2011 Elsevier Ltd. All rights reserved. 2011 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60698-3 ;PMID: 21705063 ;CODEN: LANCAO

Full text available

19
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Material Type:
Article
Add to My Research

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

The lancet oncology, 2020-10, Vol.21 (10), p.1353-1365 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30445-9 ;PMID: 32919526

Full text available

20
Colchicine in Patients with Chronic Coronary Disease
Material Type:
Article
Add to My Research

Colchicine in Patients with Chronic Coronary Disease

The New England journal of medicine, 2020-11, Vol.383 (19), p.1838-1847 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2021372 ;PMID: 32865380

Full text available

Results 1 - 20 of 13,504  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1986  (24)
  2. 1986 To 1995  (367)
  3. 1996 To 2004  (358)
  4. 2005 To 2014  (2,553)
  5. After 2014  (10,203)
  6. More options open sub menu

Subject 

  1. Humans  (13,462)
  2. Medical Research  (13,119)
  3. Male  (11,516)
  4. Middle Aged  (8,921)
  5. Adult  (7,099)
  6. Aged  (6,980)
  7. Medicine, Experimental  (5,532)
  8. Care And Treatment  (3,294)
  9. Retrospective Studies  (3,062)
  10. Analysis  (2,941)
  11. Aged, 80 And Over  (2,724)
  12. Hospitals  (2,605)
  13. Health Aspects  (2,588)
  14. Risk Factors  (2,522)
  15. Young Adult  (2,475)
  16. Adolescent  (2,344)
  17. More options open sub menu

Language 

  1. English  (13,502)
  2. Japanese  (1,323)
  3. Portuguese  (47)
  4. Norwegian  (21)
  5. French  (14)
  6. Persian  (6)
  7. Chinese  (6)
  8. Turkish  (5)
  9. Spanish  (3)
  10. Russian  (2)
  11. Arabic  (2)
  12. Dutch  (2)
  13. More options open sub menu

Searching Remote Databases, Please Wait